OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Respiratory and Critical Care Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Monographic Issue on Pulmonary Hypertension: Medical and Interventional Treatment for Chronic Thromboembolic Pulmonary Hypertension	62
Improving Medication Adherence in Asthma	42
Sleep, Circadian Rhythms, and Lung Cancer	40
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens	38
Pneumonia after Solid Organ Transplantation	30
	29
Impact of Digital Technologies on Clinical Care for Adults with Cystic Fibrosis	25
Diffuse Alveolar Hemorrhage	24
Nonmalignant Pleural Effusions	23
Advances in the Understanding and Management of Chronic Obstructive Pulmonary Disease	20
Impact of Marijuana Use on Lung Health	20
Indwelling Pleural Catheter: Management of Complications	20
Lung Transplant for Chronic Obstructive Pulmonary Disease	20
Chronic Obstructive Pulmonary Disease and Work: The Continuing Narrative	19
	18
Prevention of Aspiration: Oral Care, Antibiotics, Others	18
Imaging in the Intensive Care Unit	18
Factors Influencing Glucocorticoid Treatment Response: Mechanism-Based Strategies to Overcome Glucocorticoid Resistance and Restore GRα Function	18
Management of Dyspnea in Patients with Neuromuscular Disorders	17
The Oral–Lung Microbiome Axis in Connective Tissue Disease-Related Interstitial Lung Disease	15
Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis	15
COVID-19-Related Pleural Diseases	14
Chronic Pulmonary Aspergillosis: Clinical Presentation and Management	14
Deployment-Related Respiratory Disease: Where Are We?	14
Antibiotic Strategies for Severe Community-Acquired Pneumonia	13

Nocturnal Hypoxemia in Respiratory Medicine: Pathophysiology, Measurement, and Association with Outcomes	12
Diagnostic Approach to Interstitial Lung Diseases Associated with Connective Tissue Diseases	12
Microbiologic Diagnosis of Respiratory Infections in Critically Ill Immunocompromised Patients	11
Tissue Perfusion and Diffusion and Cellular Respiration: Transport and Utilization of Oxygen	11
Management of Pulmonary Hypertension Associated with Chronic Lung Disease	11
Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease Overlap Syndrome	11
Pulmonary Physiology and Medicine of Diving	11
Understanding the Updates in the Asthma Guidelines	10
Update on Sepsis Epidemiology in the Era of COVID-19	10
Definition and Epidemiology of Sepsis	10
How to Survive Sepsis: Patient Testimonial	10
Work-Related Sleep Disorders: Causes and Impacts	9
Bronchoscopic Lung Volume Reduction: A Review	9
Novel Therapeutic Approaches in Connective Tissue Disease-Associated Interstitial Lung Disease	9
Community-Acquired Pneumonia: Postpandemic, Not Post-COVID-19	9
Updates in Lung Cancer Screening: A Decade of Evidence	9
Lung Cancer in Special Populations	9
Lung Cancer Progress and Promise: Shaping the Future of Care	9
Survivorship Challenges and Supportive Care in Lung Cancer	9
Blood Gas Transport: Implications for O2 and CO2 Exchange in Lungs and Tissues	9
	9
Immunopathogenesis of Sarcoidosis	9
Emerging Concepts in Fibroblast Biology and Progressive Pulmonary Fibrosis	9
Beyond the Lungs—Emerging Challenges in Adult Cystic Fibrosis Care	9
Comorbid Insomnia and Sleep Apnea: From Research to Clinical Practice	8
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions	8
Management of Acutely Decompensated Pulmonary Hypertension	8
Malignant Central Airway Obstruction: What's New?	8
Aspergillus and the Lung	8
Clinical Features of COVID-19 and Differentiation from Other Causes of CAP	8
Interstitial Lung Disease Associated with Systemic Sclerosis	8
Pathological Diagnosis of Pulmonary Aspergillosis	8
Corticosteroid Treatment in Septic Shock	8
Pertussis Vaccination: The Challenges Ahead	8
Arterial Blood Gases and Acid–Base Regulation	7
“Long Haulers”	7
Aspiration Pneumonia: Preface	7
Precision Medicine to Guide Obstructive Sleep Apnea Treatment Beyond the Continuous Positive Airway Pressure	7
Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis	7
Severe Community-Acquired Pneumonia in Immunocompromised Patients	7
Cardiovascular Complications in Coronavirus Disease 2019—Pathogenesis and Management	7
Glucocorticoid Treatment in Community-Acquired Pneumonia	7
Severe Community-Acquired Pneumonia	7
Sleep and Circadian-Related Outcomes after Critical Illness	7
Use of Antiviral Agents and other Therapies for COVID-19	7
Approach to Pulmonary Nodules in Connective Tissue Disease	6
Control of Breathing	6
Chronic Pulmonary Aspergillosis as a Considerable Complication in Post-Tuberculosis Lung Disease	6
The Role of Viral Infections in the Development and Progression of COPD	6
Pulmonary Hypertension Associated with Left Heart Disease	6

Interventional Pulmonology and the Esophagus: Tracheostomy and Percutaneous Endoscopic Gastrostomy Placement	6
Intrapleural Anticancer Therapy for Malignant Pleural Diseases: Facts or Fiction?	6
Gas Exchange in the Lung	6
HIV and COVID-19 Disease	6
Early Diagnosis of Sepsis: The Role of Biomarkers and Rapid Microbiological Tests	6
Safety, Efficacy, and Effectiveness of Maternal Vaccination against Respiratory Infections in Young Infants	6
Global Trends in Occupational Lung Disease	6
Bridging Bench to the Bedside: The Imperative of Preclinical and Translational Research in Pulmonary Medicine	6